Aarkstore announce a new report  “Atopic Dermatitis – Pipeline Assessment and Market Forecasts to 2017 ” through its vast collection of market research report.

Summary

“Atopic Dermatitis – Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Atopic Dermatitis therapeutics market. The report identifies the key trends shaping and driving the global Atopic Dermatitis therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global Atopic Dermatitis sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

GlobalData has estimated the global atopic dermatitis therapeutics market to be valued at $ 728m in 2009. It is expected to grow to $ 942m at a Compound Annual Growth Rate (CAGR) of 3.3% by 2017. This growth is primarily attributed to an increase in competition among existing products and the presence of a strong pipeline with more emerging therapies. Globally, the US remains the largest market for atopic dermatitis therapeutics, and was valued at $ 415m in 2009.However, with most of the demand expected to come from the developed economies, the center of global atopic dermatitis therapeutics market activity is potentially due for a paradigm shift.

Scope

The scope of the report includes:
– Annualized global Atopic Dermatitis therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017.
– Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.
– Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include Anti-inflammatory, Corticosteroid, Interleukin Inhibitor, Antimicrobial, Immunomodulators, Protease Inhibitor, Nuclear Factor-Kappa B (NF-kB) inhibitor, Selective cannabinoid 2 receptor agonist, T-cell inhibitor, Vitamin D derivative, Cytokine Modulator, NO synthase inhibitor, Kinase Inhibitor,Calcineurin Inhibitor, Anti-pruritic, Histamine H1 antagonist, Chymase inhibitor, Anti-Neoplastic, TNF Antagonist, Non-steroid, Anti-itching, Vaccine, Combination, H4R antagonist, Serine proteinase inhibitor, RAFT modulator, Neurokinin 1 (NK1) receptor agonists, Vascular adhesion protein-1 (VAP-1) inhibitor, non-comedogenic, Fibroblast Growth Factor (FGF) inhibitor, TSLP interaction Inhibitor, Phosphodiesterase 4 (PDE4) Inhibitor, NGF receptor blocker and Glucocorticoid receptor agonist.
– Analysis of the current and future market competition in the global Atopic Dermatitis therapeutics market. The key future market players covered are Provectus Pharmaceuticals, AnGes MG Inc., Creabilis Therapeutics, Asubio Pharma, Almirall, Anacor Pharma, MIKA Pharma GmbH, Shionogi USA, Inc. and Serentis Ltd
– Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
– Key topics covered include a strategic competitor assessment, a market characterization, the unmet needs and the implications for the Atopic Dermatitis market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipelines.
– Develop business strategies by understanding the trends shaping and driving the global Atopic Dermatitis therapeutics market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to affect the global Atopic Dermatitis therapeutics market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify the emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investments and strategic partnerships.
– What’s the next big thing in the global Atopic Dermatitis therapeutics market landscape? Identify, understand and capitalize.

For more information, please visit:
http://www.aarkstore.com/reports/Atopic-Dermatitis-Pipeline-Assessment-and-Market-Forecasts-to-2017-65421.html
Or email us at press@aarkstore.com or call +919272852585

Find More Atopic Dermatitis Articles